Abound Wealth Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
Abound Wealth Management's LGND Position: Q3 2026 in Review
Abound Wealth Management held its Ligand Pharmaceuticals (LGND) position steady in Q3 2026 at 1 share worth $313. The position accounts for ﹤0.01% of the portfolio, ranked #1095.
Abound Wealth Management first reported a position in LGND in Q3 2024 and has held it in 9 quarters since. The position peaked at $317 in Q2 2026. 433 funds tracked by Wall St. Rank hold LGND as of Q3 2026.
- Abound Wealth Management held 1 share of Ligand Pharmaceuticals worth $313 as of Q3 2026.
- Abound Wealth Management left its Ligand Pharmaceuticals share count unchanged in Q3 2026.
- Ligand Pharmaceuticals made up ﹤0.01% of Abound Wealth Management's portfolio in Q3 2026, its #1095 holding.
- Abound Wealth Management first reported a position in Ligand Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
- Abound Wealth Management's Ligand Pharmaceuticals position peaked at $317 in Q2 2026.
- 433 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.
Based on Abound Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.